secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001193125-23-183869
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA Warning Letter to Outset Medical over Tablo System promotion and TabloCart clearance
--------------------------------------------------------------------------------

- FDA Warning Letter dated July 5, 2023 received July 6, 2023, citing two observations: promotional material for CRRT outside Tablo indications, and TabloCart needing 510(k) clearance.
- Company believes CRRT issue addressed via labeling/promotional changes; TabloCart launched Q3 2022 with immaterial sales to date.
- Warning Letter does not restrict manufacture, shipment, or require withdrawal of Tablo System from U.S. market.
- Company to respond within 15 business days; will cooperate with FDA and may submit 510(k) for TabloCart.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000119312523183869/0001193125-23-183869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000119312523183869/d511727d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-183869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer